CDSCO License for Dermal dilator
Medical Device Information
Intended Use
A device to be temporarily implanted subcutaneously to dilate the surrounding skin. Usually, a balloon is implanted subcutaneously where solutions including saline solution are infused.

Comprehensive CDSCO Licensing Guide for Dermal Dilators (Class B Medical Device)
As seasoned regulatory consultants with over 25 years of experience and having assisted more than 500 companies in securing CDSCO approvals, we understand the nuances and critical steps manufacturers and importers must follow to bring dermal dilators to the Indian market. Dermal dilators, which are designed for temporary subcutaneous implantation to expand skin tissue—often through saline infusion—fall under the dermatological and plastic surgery device category. Classified as Class B under CDSCO regulations, these devices require a well-structured licensing approach for manufacturing and import.
CDSCO Regulatory Framework for Dermal Dilators
The Central Drugs Standard Control Organization (CDSCO) governs the regulation of medical devices in India, ensuring safety, efficacy, and quality. Dermal dilators, notified under the Gazette Notification 29/Misc./03/2020-DC (dated 26.7.2021), are classified as Class B devices, requiring a manufacturing license under MD5 (issued by State Authorities) or an import license under MD15 (issued by Central Authorities).
Risk Classification and License Requirements for Dermal Dilators
According to CDSCO’s risk classification, dermal dilators are Class B devices—meaning they pose moderate risk and require compliance with regulatory prerequisites including testing, audits, and documentation. For manufacturers, an MD5 license (Application Form MD3) is mandatory, while importers must secure an MD15 license for marketing these devices in India.
Manufacturing License Process (MD5) for Dermal Dilators
The MD5 license process involves multiple phases:
Test License (Form MD13): Before applying for the manufacturing license, manufacturers must obtain a test license valid for 1.5 to 2 months. This license permits production of samples for testing.
Testing: Samples of the dermal dilator must be tested at government-approved laboratories to verify compliance with safety and performance standards. A list of such Testing Laboratories is available on the CDSCO portal.
Document Preparation: Compilation of comprehensive technical and quality documents including Device Master File (DMF), Plant Master File (PMF), Essential Principles Checklist, Risk Management File, and Quality Management System (QMS) documentation is essential.
Application Submission: Submit the manufacturing license application (Form MD3) via the CDSCO MD Online Portal.
Audit: A notified body conducts an on-site audit of manufacturing facilities, quality systems, and documentation. Refer to the Notified Bodies List for authorized auditors.
Query Resolution: Address any queries raised by the licensing authority or notified body.
License Grant: Upon satisfactory completion of all steps, the State Licensing Authority issues the MD5 manufacturing license.
For a detailed walkthrough, our MD5 License Guide offers a step-by-step overview.
Manufacturing License Documents Required for Dermal Dilators
Successful license application depends on meticulous documentation, including:
- Company Constitution and Registration Certificates
- Proof of Ownership or Lease of Manufacturing Premises
- Qualification and Experience Details of Technical Staff
- Fire NOC and Pollution Control Board NOC
- Device Master File (DMF) detailing design specifications and manufacturing processes (Device Master File Guide)
- Plant Master File (PMF) outlining manufacturing setup and quality systems (Plant Master File Guide)
- Essential Principles Checklist confirming adherence to regulatory standards
- Risk Management File demonstrating systematic risk analysis and mitigation (Risk Management)
- Test Reports from accredited laboratories
- Product Labels and Instructions for Use (IFU)
- Quality Management System (QMS) documentation compliant with ISO 13485:2016
Import License Process (MD15) for Dermal Dilators
Importers seeking to market dermal dilators in India must apply for an MD15 license through the Central Licensing Authority. The process includes:
Documentation Preparation: Compile documents including valid manufacturing license from the country of origin, Free Sale Certificate, ISO 13485:2016 certification, CE Certificate, DMF, PMF, and wholesale license.
Application Submission: File the import license application (Form MD14) on the CDSCO MD Online Portal.
Query Resolution: Respond promptly to any departmental queries.
License Grant: The MD15 import license is issued typically within 5-6 months.
For more information, refer to our Import License Guide.
Import License Documents Required for Dermal Dilators
- Valid Manufacturing License from the Country of Origin
- Free Sale Certificate
- ISO 13485:2016 Certification
- CE Certificate or Equivalent
- Device Master File and Plant Master File
- Wholesale License
- Company Constitution and Registration
Timeline and Processing Duration for Dermal Dilator Licensing
License Type | Process Steps | Approximate Duration |
---|---|---|
MD5 (Manufacturing) | Test license, Testing, Documentation, Audit, Query resolution | 3-4 months |
MD15 (Import) | Documentation, Application, Query resolution | 5-6 months |
Government Fees and Costs for CDSCO Licensing
- MD5 License: Rs. 5000 per application + Rs. 500 per product
- MD15 License: For Class B devices like dermal dilators, Rs. 2000 per site + Rs. 1000 per product
Additional costs include testing fees at government approved laboratories and fees for notified body audits.
Common Challenges and Practical Solutions
Challenge 1: Delays in Testing and Audit
- Solution: Initiate test license application early and pre-select laboratories with faster turnaround. Maintain open communication with notified bodies to schedule audits promptly.
Challenge 2: Incomplete Documentation
- Solution: Utilize comprehensive checklists and templates for Device Master Files and Risk Management Files. Engage expert consultants for document reviews.
Challenge 3: Query Resolution Bottlenecks
- Solution: Prepare detailed responses supported by technical evidence. Keep regulatory consultants engaged to expedite clarifications.
Expert Consultation and Support
Navigating CDSCO regulations for dermal dilators requires expertise in documentation, testing, and audit management. Our team offers tailored consulting services including:
- Gap analysis of existing documentation
- Assistance in preparation of DMF, PMF, Risk Management files
- Coordination with testing laboratories and notified bodies
- End-to-end application filing and follow-up
Getting Started with Your CDSCO License Application
To launch your dermal dilator manufacturing or import business in India, follow these actionable steps:
Classify Your Device: Confirm your device’s Class B status using the Medical Device Classification guide.
Initiate Test License Application: Apply for Form MD13 on the CDSCO MD Online Portal to begin product testing.
Engage Testing Labs: Identify and liaise with government-recognized testing laboratories early.
Prepare Technical Documentation: Start compiling the Device Master File, Plant Master File, and Risk Management documentation.
Schedule Audits: Contact notified bodies from the official list to plan your facility audit.
Consult Experts: Leverage regulatory consultancy to avoid common pitfalls and accelerate approvals.
By meticulously following these guidelines and leveraging our extensive experience, manufacturers and importers can confidently navigate the CDSCO licensing pathway for dermal dilators, ensuring timely market entry and regulatory compliance.